SAB Biotherapeutics (SABS) Assets: 2020-2025
Historic Assets for SAB Biotherapeutics (SABS) over the last 5 years, with Sep 2025 value amounting to $183.4 million.
- SAB Biotherapeutics' Assets rose 241.00% to $183.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $183.4 million, marking a year-over-year increase of 241.00%. This contributed to the annual value of $44.2 million for FY2024, which is 47.35% down from last year.
- Per SAB Biotherapeutics' latest filing, its Assets stood at $183.4 million for Q3 2025, which was up 508.87% from $30.1 million recorded in Q2 2025.
- SAB Biotherapeutics' 5-year Assets high stood at $183.4 million for Q3 2025, and its period low was $28.3 million during Q3 2023.
- In the last 3 years, SAB Biotherapeutics' Assets had a median value of $44.2 million in 2024 and averaged $61.2 million.
- In the last 5 years, SAB Biotherapeutics' Assets tumbled by 55.09% in 2022 and then soared by 241.00% in 2025.
- SAB Biotherapeutics' Assets (Quarterly) stood at $81.1 million in 2021, then slumped by 37.26% to $50.9 million in 2022, then surged by 64.90% to $83.9 million in 2023, then slumped by 47.35% to $44.2 million in 2024, then soared by 241.00% to $183.4 million in 2025.
- Its Assets stands at $183.4 million for Q3 2025, versus $30.1 million for Q2 2025 and $38.1 million for Q1 2025.